5/5 mg vial + 2 mL BAC water: Concentration = 2,500 mcg BPC-157 + 2,500 mcg TB-500 per mL 250 mcg dose (of each) = 10 units (0.1 mL) on a 100-unit insulin syringe 500 mcg dose (of each) = 20 units (0.2 mL) on a 100-unit insulin syringe Doses per vial: 20 doses at 250 mcg each, or 10 doses at 500 mcg each Supplies Needed (4-Week Loading at 500 mcg/day) 3 vials BPC-157/TB-500 blend (5/5 mg each) provides 30 doses at 500 mcg, covers 28 days with margin 3 vials bacteriostatic water (30 mL each) 30 insulin syringes (2931 gauge, 100-unit) Alcohol prep pads Administration Injection Technique Standard subcutaneous injection
More specifically, even with prevalent realistic droplet size distributions as found in administered shots of over-the-counter spray productsthe delivered dose at the target infective site (i.e., the nasopharynx) registers an improvement of approximately 2 orders-of-magnitude with the new IU protocol
Specifications Purity: 99% (HPLC Verified) Ratio: 12.5 mg / 2.5 mg Appearance: Lyophilized Powder Format: Research Compound Storage: Store at 20C
While tripeptides have been introduced as promising therapeutic agents in earlier sections, this part contrasts their therapeutic potential with larger peptides, based on their physicochemical characteristics and performance in wound healing models